Precision Medicine in Control of Visceral Leishmaniasis Caused by L. donovani
Precision medicine and precision global health in visceral leishmaniasis (VL) have not yet been described and could take into account how all known determinants improve diagnostics and treatment for the individual patient. Precision public health would lead to the right intervention in each VL endem...
Enregistré dans:
Auteur principal: | Eduard E. Zijlstra |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/379b6f9beb104eb79b65e6f37d4d87fc |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Visceral leishmaniasis and HIV coinfection: current perspectives
par: Lindoso JAL, et autres
Publié: (2018) -
Hepatomegaly Associated with Non-Obstructive Sinusoidal Dilation in Experimental Visceral Leishmaniasis
par: Kota Maeda, et autres
Publié: (2021) -
Pediatric visceral leishmaniasis in Tartous, Syria
par: Ali Othman Hamwi, et autres
Publié: (2020) -
Magnitude of visceral leishmaniasis and poor treatment outcome among HIV patients: meta-analysis and systematic review
par: Alemayehu M, et autres
Publié: (2016) -
Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis
par: Want MY, et autres
Publié: (2017)